In Brief
Nuclear-import receptors can reverse phase separation and aggregation of proteins with prion-like domains, including FUS and TDP-43, to mitigate neurodegeneration in vivo.
INTRODUCTION
There are no effective therapies for several fatal neurodegenerative disorders, including amyotrophic lateral sclerosis (ALS), frontotemporal dementia (FTD), and multisystem proteinopathy (MSP) in which specific RNA-binding proteins (RBPs) with prion-like domains (PrLDs) mislocalize and aggregate in the cytoplasm of degenerating cells (Harrison and Shorter, 2017) . For example, wild-type (WT) or mutant FUS, TAF15, and EWSR1 are depleted from the nucleus and form cytoplasmic aggregates in degenerating neurons in some ALS/FTD cases, whereas in MSP, WT, or mutant hnRNPA1 and hnRNPA2 exhibit this phenotype in degenerating tissues, including muscle, brain, and bone (Harrison and Shorter, 2017) . For these RBPs with a PY-nuclear localization signal (NLS) (Lee et al., 2006) , as well as TDP-43, which harbors a canonical NLS (cNLS) ( Figure 1A ), a major pathological event is mislocalization from the nucleus to cytoplasmic aggregates (Harrison and Shorter, 2017) . Indeed, defects in nuclear transport contribute to ALS, FTD, and MSP (Chou et al., 2018; Kim and Taylor, 2017) .
PrLDs possess a low-complexity, amino-acid composition similar to prion domains (PrDs), which enable certain yeast proteins (e.g., Sup35) to form prions (March et al., 2016) . PrDs and PrLDs are enriched in Gly and uncharged polar amino acids, including Gln, Asn, Tyr, and Ser. PrDs of yeast proteins enable beneficial liquid-liquid phase separation (LLPS) and prionogenesis (Franzmann et al., 2018; March et al., 2016) . PrLDs of human RBPs drive their pathological aggregation and disease-linked mutations in PrLDs can accelerate aggregation (March et al., 2016) . However, PrLDs in human RBPs also play important roles in functional protein-protein interactions and drive LLPS events that underpin biogenesis of functional membraneless organelles, including stress granules (SGs) and nuclear paraspeckles (March et al., 2016) . Thus, PrLDs switch from intrinsically unfolded states in monodisperse solution to condensed multimeric liquid phases in which PrLDs retain disordered character. These liquid compartments exhibit rapid internal dynamics and are sustained by transient, multivalent intermolecular contacts between PrLDs and between PrLDs and other RBP domains (Monahan et al., 2017) . RBP liquids can mature into solid hydrogels comprised of stable fibrils maintained by intermolecular cross-b contacts between PrLDs (Molliex et al., 2015; Murakami et al., 2015; Patel et al., 2015) . Disease-linked mutations in PrLDs (e.g., hnRNPA1
D262V ) accelerate fibrillization and aberrant phase transitions to the solid state Molliex et al., 2015; Murakami et al., 2015; Patel et al., 2015) . These aberrant solid, gel-like phases of RBPs with PrLDs are closely tied to neurodegeneration (Harrison and Shorter, 2017) .
Agents that reverse fibrillization and aberrant phase transitions of RBPs with PrLDs while simultaneously restoring their functionality and nuclear localization could mitigate neurodegeneration by eradicating: (1) any toxic gain of function of misfolded species, and (2) any loss of function due to sequestration in cytoplasmic aggregates (Shorter, 2016) . Previously, we engineered a protein disaggregase from yeast, Hsp104, to rapidly disaggregate TDP-43 and FUS fibrils linked to ALS/FTD (Shorter, 2016) . However, metazoa lack Hsp104. Whether metazoa harbor machinery that disaggregates fibrils and deleterious hydrogels formed by RBPs with PrLDs is unknown. Here, we establish that nuclear-import receptors (NIRs) prevent and reverse fibrillization of RBPs with an NLS. Elevating NIR expression prevents RBPs with PrLDs accumulating in SGs, restores nuclear RBP localization and function, and rescues degeneration caused by disease-linked RBPs. Thus, NIRs could therapeutically restore RBP homeostasis in ALS, FTD, MSP, and other deadly neurodegenerative disorders.
RESULTS
Karyopherin-b2 Is a Molecular Chaperone for RBPs with a PY-NLS NIRs bind NLSs tightly and break hydrophobic contacts between FG-repeat-rich nucleoporins as they traverse the nuclear pore during nuclear transport (Schmidt and Gö rlich, 2016) . Thus, we reasoned that NIRs might also bind to the NLSs of RBPs with PrLDs and disrupt intermolecular contacts between PrLDs to antagonize pathological fibrillization. To assess this possibility, we used pure RBP fibrillization assays. Here, RBPs are purified with an N-terminal GST tag, which can be selectively removed by TEV protease to elicit rapid assembly of RBP fibrils that bear close ultrastructural resemblance to those that accumulate in disease (Couthouis et al., 2011 (Couthouis et al., , 2012 Johnson et al., 2009; Kim et al., 2013; Sun et al., 2011) . Under our conditions, RBPs rapidly fibrillize and do not form macroscopic liquid droplets. Thus, we can assess NIR activity under conditions where fibrillization is the dominant pathway.
We assessed spontaneous FUS, TAF15, EWSR1, hnRNPA1, and hnRNPA2 fibrillization (i.e., in the absence of preformed fibrils) in the absence or presence of their specific NIR, Karyopherin-b2 (Kapb2, also called Transportin-1 or Importin-b2) (Lee et al., 2006) . As negative controls, we used Kapb2 W460A:W730A and Importin-a (Impa) plus Karyopherin-b1 (Kapb1), which unlike Kapb2, do not bind the PY-NLS of these RBPs (Lee et al., 2006) . Kapb2 strongly inhibited FUS, TAF15, EWSR1, hnRNPA1, and hnRNPA2 fibrillization, whereas Kapb2 W460A:W730A or Impa and Kapb1 did not ( Figures 1B, 1C , and S1A). The half maximal inhibitory concentration (IC 50 ) was $1-2 mM for each RBP ( Figure 1D ). Deleting the PY-NLS from FUS, TAF15, EWSR1, hnRNPA1, and hnRNPA2 did not affect fibrillization but diminished inhibition by Kapb2 (Figures 1B and S1A) . Thus, Kapb2 is a molecular chaperone for RBPs with a PY-NLS.
The hnRNPA1 and hnRNPA2 PY-NLSs are immediately C-terminal to a hexapeptide in their PrLDs (residues 259-264 in hnRNPA1 and 287-292 in hnRNPA2), which is critical for fibrillization (Figure 1A) . Deletion of this hexapeptide prevents DNLS , EWSR1, EWSR1 DNLS , hnRNPA1, hnRNPA1 DNLS , hnRNPA2, or hnRNPA2 DNLS (5 mM) were incubated with buffer, Kapb2
(5 mM), Kapb2 W460A:W730A (5 mM), or Impa (5 mM) plus Kapb1 (5 mM). Fibrillization was assessed by sedimentation. Values are means ± SEM (n = 3).
(C) Fibrillization reactions performed as in (B) and processed for EM. Arrows denote fibrils. Scale bar, 0.5 mm.
(D) Kapb2 IC 50 s for fibrillization of indicated RBPs (5 mM) performed as in (B) . IC 50 for FUS R495X could not be determined and is >20 mM.
(E) FUS (5 mM) was incubated with buffer, Kapb2 (5 mM), HDAC1 (5 mM or 50 mM), or anti-FUS antibody (5 mM). Fibrillization was assessed by sedimentation. Values are means ± SEM (n = 3).
(F) FUS, TAF15, EWSR1, hnRNPA1, or hnRNPA2 (5mM) were incubated as in (B) in the absence or presence of Kapb2 (5 mM) plus or minus Ran GDP or Ran GTP (25 mM). Fibrillization was assessed by sedimentation. Values are means ± SEM (n = 3). , or TDP-43 DNLS (5 mM) were incubated with buffer Kapb2 (5 mM) or Impa (5 mM) plus Kapb1 (5 mM). Fibrillization was assessed by sedimentation. Values are means ± SEM (n = 3). See also Figure S1 .
hnRNPA1 and hnRNPA2 fibrillization . Kapb2 binding close to this region would prevent cross-b contacts between PrLDs that drive fibrillization. By contrast, the PY-NLS of FUS, EWSR1, and TAF15 is at the C-terminal end, distal to the N-terminal PrLD that drives fibrillization ( Figure 1A) . Thus, could other FUS-binding proteins inhibit fibrillization? An anti-FUS antibody that recognizes the FUS PY-NLS did not inhibit FUS fibrillization ( Figures 1E and S1B) , and neither did HDAC1 ( Figures  1E and S1B ), which binds to the FUS Gly-rich domain (residues 156-262) and C-terminal region (residues 450-526) . Thus, FUS fibrillization is not inhibited by any FUS-binding protein, whereas Kapb2 engages the FUS PY-NLS to abolish FUS fibrillization. Kapb2 binds the PY-NLS of cargo in the cytoplasm and transports cargo across the nuclear pore to the nucleus. A small GTPase, Ran, regulates Kapb2-cargo interactions and nucleartransport directionality via its GTPase cycle. Ran GDP is concentrated in the cytoplasm and allows Kapb2-cargo interactions, whereas Ran GTP is concentrated in the nucleus and dissociates
Kapb2 from cargo upon arrival in the nucleus (Kim and Taylor, 2017 (Harrison and Shorter, 2017) . The PY-NLS is deleted in FUS R495X (Figure 1A) , and the critical Pro of the PY-NLS is mutated to Leu in FUS P525L , which reduces binding to Kapb2 (Zhang and Chook, 2012) . Nonetheless, Kapb2 reduced FUS P525L aggregation by $50% ( Figures 1G  and S1D ), although the IC 50 was elevated $3.7-fold ( Figure 1D ). Kapb2 had limited activity against FUS R495X ( Figures 1D, 1G , and S1D). By contrast, Kapb2 abolished fibrillization of the diseaselinked RBP variants: FUS   R234L   , FUS   H517Q   , FUS  R521C , FUS  R521H ,   TAF15  G391E ,  TAF15  R408C ,  EWSR1  G511A ,  EWSR1  P552L ,   hnRNPA1 D262V , hnRNPA1 D262N , and hnRNPA2 D290V ( Figure 1G ) (Harrison and Shorter, 2017) . These included ALS-linked FUS variants with mutations in the PY-NLS (H517Q, R521C, and R521H), which do not reduce Kapb2 binding as much as P525L (Zhang and Chook, 2012) . Thus, Kapb2 chaperones diverse disease-linked mutant RBPs.
NIRs Prevent TDP-43 Fibrillization TDP-43 lacks a PY-NLS but harbors a cNLS that is decoded by Impa. Impa is then bound by Kapb1 and transported to the nucleus (Nishimura et al., 2010 , and TDP-43 D79-98 , which lack the cNLS, resisted inhibition by Impa plus Kapb1 ( Figures  1H and S1E ). Ran GTP but not Ran GDP reduced inhibition of TDP-43 fibrillization by Impa plus Kapb1 ( Figure S1F ). The TDP-43 cNLS is distant from the fibrillogenic PrLD ( Figure 1A ), which might indicate an allosteric inhibitory effect upon NIR binding. We suggest that elevating NIR expression could block nucleation of pathological fibrils and disease onset.
Kapb2 Inhibits Seeded Fibrillization of Diverse RBPs with a PY-NLS
In ALS/FTD, disease pathology spreads between contiguous brain regions. Spreading may be due to transmission of self-templating, prion-like fibrils from cell to cell. Once a self-templating fibril gains access to a new cell, it converts soluble protein to the fibrillar form (March et al., 2016 2H , S2D, and S2E). Thus, NIRs could be utilized to prevent prion-like spread of self-seeding conformers during ALS, FTD, and MSP progression.
Kapb2 Rapidly Disaggregates FUS, TAF15, and EWSR1 Fibrils Therapeutic agents may also need to clear fibrils rather than simply impede their assembly. Remarkably, Kapb2 rapidly dissolved preformed FUS, TAF15, and EWSR1 fibrils within $15-20 min . By contrast, Kapb2 W460A:W730A , Impa and Kapb1, an anti-FUS-PY-NLS antibody, and HDAC1 had no effect . The half maximal effective concentration (EC 50 ) of Kapb2 was $2.5 mM ( Figure 3G ). This disaggregation activity was inhibited by Ran GTP , which disrupts Kapb2:PY-NLS interactions, but not by Ran GDP , which permits them ( Figures 3A, 3C , and 3E). Thus, Kapb2 rapidly disaggregates PY-NLS bearing cargo, and this activity is likely restricted to the cytoplasm. To determine the nature of the soluble disaggregated products, we disaggregated His-tagged FUS fibrils with biotinylated-Kapb2 (bio-Kapb2). In the presence of buffer or Ran GDP , depletion of bio-Kapb2 from the soluble disaggregated fraction codepleted the soluble FUS ( Figure 3I ). Likewise, depletion of His-FUS co-depleted bio-Kapb2 ( Figure 3I ). Thus, the major products of Kapb2-driven disaggregation are soluble Kapb2: FUS complexes. Ran GTP separated Kapb2 from disaggregated FUS ( Figure 3I ). Thus, each Kapb2 may extract a single FUS monomer from the FUS fibril to form a soluble Kapb2:FUS complex, which can then be transported to the nucleus. In this way, disaggregated FUS would not reaggregate in the cytoplasm or during transit across the nuclear pore.
The rapidity of Kapb2-driven disaggregation was unanticipated. Indeed, the protein-disaggregase machinery from yeast, Hsp104, Sse1, Ssa1, and Ydj1 were unable to disaggregate FUS, TAF15, and EWSR1 fibrils over this short time frame ( Figures  S3D-S3F ). Even a potentiated Hsp104 variant, Hsp104 A503S , required longer times to dissolve FUS and TAF15 fibrils, and was unable to dissolve EWSR1 fibrils ( Figures S3D-S3F ). Likewise, the human protein-disaggregase system comprised of Hsp110, Hsp70, and Hsp40 (Shorter, 2016) only partially dissolved FUS, TAF15, and EWSR1 fibrils ( Figures S3D-S3F) . Thus, the ability of Kapb2 to disaggregate FUS, TAF15, and EWSR1 fibrils was potent compared to canonical disaggregases.
Kapb2 did not display general protein-disaggregation activity and did not disaggregate proteins without a PY-NLS. Unlike Hsp104, Hsp104
A503S
, and human Hsp110, Hsp70, and Hsp40, Kapb2 did not disaggregate denatured luciferase (Figure S3G) . Kapb2 was also unable to disaggregate FUS DNLS , TAF15 DNLS , EWSR1 DNLS ( Figure S3H ), or TDP-43 fibrils ( Figure 3J ).
Remarkably, Impa and Kapb1 disaggregated TDP-43 and TDP-43 Q331K fibrils ( Figures 3J and S3I ). Impa and Kapb1 were not as effective as Hsp104
, but were more effective than Hsp104 or human Hsp110, Hsp70, and Hsp40 ( Figure 3J ). Impa plus Kapb1 had limited activity against (that lacks the NLS) fibrils (Figure S3J) or FUS, TAF15, and EWSR1 fibrils ( Figures 3A-3F ). Collectively, NIRs may function broadly to disaggregate NLS-bearing cargo.
Kapb2 rapidly disaggregated fibrils formed by disease-linked FUS, EWSR1, and TAF15 variants with an EC 50 of $2-3 mM (Figures 3G and 3K (5mM) plus or minus FUS fibrils (5% wt/wt), (B) TAF15 (5 mM) plus or minus TAF15 fibrils (5% wt/wt), (C) EWSR1 (5 mM) plus or minus EWSR1 fibrils (5% wt/wt), (D) hnRNPA1 (5 mM) plus or minus hnRNPA1 fibrils (5% wt/wt), (E) hnRNPA2 (5 mM) plus or minus hnRNPA2 fibrils (5% wt/wt), or (F) TDP-43 (5 mM) plus or minus TDP-43 fibrils (5% wt/wt) was incubated with buffer, Kapb2 (5 mM), Kapb2 W460A:W730A (5 mM), or Impa (5 mM) plus Kapb1 (5 mM). Fibrillization was assessed by sedimentation. Values are means ± SEM (n = 3). (G) FUS (5 mM) was incubated with FUS fibrils (5% wt/wt) with or without Kapb2 (5 mM) and processed for EM. Scale bar, 10 mm.
(H) Disease-linked RBP (5 mM) plus or minus fibrils of the same disease-linked RBP (5% wt/wt) was incubated with buffer, Kapb2 (5 mM), or Impa (5 mM) plus Kapb1 (5 mM). Fibrillization was assessed by sedimentation. Values are means ± SEM (n = 3). See also Figure S2 . (A and B) , TAF15 (C and D) , or EWSR1 (E and F) fibrils (5 mM monomer) were incubated with buffer, Kapb2 (5 mM), Kapb2 W460A:W730A (5 mM), or Impa (5 mM) plus Kapb1 (5 mM) in the absence or presence of Ran GDP or Ran GTP (25 mM). Disaggregation was assessed by turbidity (A, C, and E) . Values are means ± SEM (n = 3). Disaggregation was also assessed by EM (B, D, and F) . Scale bar, 0.5 mm.
(G) Kapb2 EC 50 s for disaggregation of indicated RBP (5 mM monomer) performed as in (A) . EC 50 for FUS R495X could not be determined and is >20 mM.
(H) FUS fibrils (5 mM monomer) were incubated with Kapb2 (5 mM), HDAC1 (5 or 50 mM), or anti-FUS antibody (5 mM). Disaggregation was assessed by turbidity.
Values are means ± SEM (n = 3).
(I) His-FUS fibrils (5 mM monomer) were disassembled with bio-Kapb2 (5 mM). Soluble disaggregation products were recovered and incubated with Ran GDP or Ran GTP (25 mM). Kapb2 was depleted with neutravidin Sepharose or His-FUS was depleted with Ni-NTA. Input, bound, and unbound fractions were processed for immunoblot.
(J) TDP-43 fibrils (5 mM monomer) were incubated with Kapb2 (5 mM), Impa (5 mM) plus Kapb1 (5 mM), Hsp104 (5 mM) plus Sse1 (1 mM), Ssa1 (1 mM) and Ydj1 (1 mM), Hsp104 A503S (5 mM) plus Sse1 (1 mM), Ssa1 (1 mM) and Ydj1 (1 mM), or Hsp110 (Apg2; 5 mM), Hsp70 (Hsc70; 5 mM), and Hsp40 (Hdj1; 5 mM). (Molliex et al., 2015; Patel et al., 2015) . However, these droplets are not required for fibrillization of FUS, hnRNPA1, or other RBPs with PrLDs, which fibrillize under conditions where liquid droplets do not . Indeed, under our conditions employed above, RBPs rapidly fibrillize and do not dwell in macroscopic liquid states (Couthouis et al., 2011 (Couthouis et al., , 2012 Johnson et al., 2009; Kim et al., 2013; Sun et al., 2011) . To assess how Kapb2 affects FUS LLPS, we omitted TEV protease and increased FUS concentration, which enables condensation of spherical FUS drops that readily fuse indicating liquid behavior ( Figure S4A ; Movie S1). Kapb2 abolished FUS LLPS, whereas Kapb2 W460A:W730A had no effect ( Figure S4A ). Thus, Kapb2 engages the FUS PY-NLS to prevent LLPS. Next, we assessed FUS P525L , which formed smaller and more irregular droplet structures ( Figure S4B ). Thus, the P525L mutation impairs formation of large FUS liquid droplets and promotes assembly of smaller aberrant, more solid-like structures (Figure S4B) (Murakami et al., 2015) . Kapb2 abolished formation of these FUS P525L assemblies, whereas Kapb2 W460A:W730A had little effect ( Figure S4B ). Thus, Kapb2 antagonizes FUS P525L phase separation.
Kapb2, but not Kapb2 W460A:W730A , rapidly dissolved preformed FUS liquids in seconds ( Figure S4C ; Movies S1 and S2 Figure S4E ), which was readily pipetted and rapidly resolved at 25 C (Molliex et al., 2015) . Rheology confirmed that this phase was a viscous liquid as the storage modulus (G 0 Figures  S4E-S4G) . Thus, Kapb2 engages the hnRNPA1 PY-NLS to reverse hnRNPA1 LLPS.
Kapb2 Dissolves Aberrant FUS and hnRNPA1 Hydrogels Fibrils formed by the PrLDs or full-length FUS, TAF15, EWSR1, hnRNPA1, and hnRNPA2 can associate into macroscopic hydrogels (Harrison and Shorter, 2017) . These stable assemblies may originate from functional liquid states of RNP granules and are closely tied to neurotoxicity (Molliex et al., 2015; Murakami et al., 2015; Patel et al., 2015) . Could Kapb2 reverse aberrant phase transitions to these structures? At 4 C, FUS formed hydrogels comprised of fibrillar networks ( Figures 4A and 4B ), which could not be pipetted or disassembled by shifting to 25 C. FUS formed strong gels with G 0 at $4,235 Pa ( Figure 4C ) and G 00 at $866 Pa ( Figure 4D ). These measures of elasticity (G 0 ) and viscosity (G 00 ) indicate that FUS hydrogels have similar material properties to an $0.5%-1% agarose gel and are stiffer than cells and some human tissues (Levental et al., 2007) . Remarkably, Kapb2 dissolved these stable FUS hydrogels by dismantling the fibrillar matrix underlying the gel (Figures 4B and 4G) . After dissolution by Kapb2, G 0 and G 00 were $0.12 Pa, consistent with obliteration of FUS fibrils ( Figures 4C and 4D ). Kapb2
W460A:W730A had no visible effect ( Figure 4G ), but reduced G 0 and G 00 by $30%, indicating decreased viscoelasticity (Figures 4E and 4F) . Thus, FUS hydrogels are not irreversible, but can be rapidly deconstructed by Kapb2. Kapb2 could not dissolve hydrogels formed by a FUS PrLD fragment, FUS ( Figure 4H ). Thus, Kapb2 engages the FUS PY-NLS to dissolve FUS hydrogels.
Could Kapb2 disrupt hnRNPA1 hydrogels? At 4 C, hnRNPA1 forms solid-like gels very slowly after rapidly populating a reversible viscous liquid phase at early times ( Figure S4E ) (Molliex et al., 2015) . After a few weeks, hnRNPA1 liquids mature into solid, strong gels comprised of fibril networks, which cannot be pipetted ( Figures 4I and 4J ). The G 0 of hnRNPA1 gels was $21,099 Pa and G 00 was $7,438 Pa ( Figures 4K and 4L ), which are material properties akin to an $1%-1.5% agarose gel (Levental et al., 2007) . Kapb2 partially disassembled hnRNPA1 hydrogels and disrupted the underlying fibril network ( Figures 4J and 4M ). However, some parts of the gel remained intact ( Figure 4M ). The residual hnRNPA1 gel was greatly weakened by $99% (Figures 4K and 4L). Kapb2
W460A:W730A did not dissolve hnRNPA1 hydrogels but weakened them by $40%-50% ( Figures 4K and 4L ). This effect was specific as GFP did not alter G 0 and G 00 ( Figures 4N  and 4O ). Kapb2
W460A:W730A may weaken hnRNPA1 hydrogels (K) RBP fibrils (5 mM monomer) were incubated with buffer or Kapb2 (5 mM). Disaggregation was assessed by turbidity. Values are means
, or hnRNPA1 DNLS fibrils (5 mM monomer) were incubated with Kapb2 (5 mM), Kapb2 W460A:W730A (5 mM), Hsp104
(5 mM) plus Sse1 (1 mM), Ssa1 (1 mM) and Ydj1 (1 mM), Hsp104 A503S (5 mM) plus Sse1 (1 mM), Ssa1 (1 mM) and Ydj1 (1 mM), or Hsp110 (Apg2; 5 mM), Hsp70 (Hsc70; 5 mM), and Hsp40 (Hdj1; 5 mM). Disaggregation was assessed by sedimentation. Values are means ± SEM (n = 3).
(M) hnRNPA2, hnRNPA2 D290V , or hnRNPA2 DNLS fibrils (5 mM monomer) were incubated with Kapb2 (5 mM), Kapb2 W460A:W730A (5 mM), Hsp104 (5 mM) plus Sse1
(1 mM), Ssa1 (1 mM) and Ydj1 (1 mM), Hsp104 A503S (5 mM) plus Sse1 (1 mM), Ssa1 (1 mM) and Ydj1 (1 mM), or Hsp110 (Apg2; 5 mM), Hsp70 (Hsc70; 5 mM), and Hsp40 (Hdj1; 5 mM). Disaggregation was assessed by sedimentation. Values are means ± SEM (n = 3). See also Figure S3 . (legend continued on next page) by breaking intermolecular contacts, an activity that enables Kapb2 to traverse the nuclear pore (Schmidt and Gö rlich, 2016) . Thus, an ability to break intermolecular contacts and bind the cargo PY-NLS enables Kapb2 to dismantle strong gels formed by RBPs with a PY-NLS. hnRNPA1 D262V rapidly formed hydrogels overnight and at lower concentrations than hnRNPA1. Indeed, hnRNPA1 D262V only briefly populated a liquid phase (Molliex et al., 2015) . Kapb2 was unable to visibly dissolve hnRNPA1 D262V hydrogels.
Nonetheless, even with hnRNPA1 D262V in excess, Kapb2
severely weakened the hydrogel as G 0 and G 00 declined by $82%-88% ( Figures 4P and 4Q ). Indeed, Kapb2 converted strong hnRNPA1 D262V gels that could not be pipetted to weak gels that were readily pipetted. Thus, MSP-linked hnRNPA1 D262V forms hydrogels that are stronger and more difficult to reverse, which may underlie MSP pathogenesis. Nonetheless, Kapb2 liquidizes solid-like hnRNPA1 D262V gels and thus reverses aberrant phase transitions. Kapb2 was unable to dissolve hydrogels formed by hnRNPA1 G274A:P288A:Y289A , which bears PY-NLS mutations that reduce Kapb2 binding (Lee et al., 2006) . Nonetheless, Kapb2 weakened this structure by $57% ( Figures 4R and 4S ). Thus, Kapb2 weakens hydrogels formed by RBPs that lack a PY-NLS, but weakens, liquidizes, and dissolves hydrogels formed by RBPs with a PY-NLS.
Kapb2 Antagonizes Cytoplasmic Aggregation and Restores Nuclear Localization of FUS, EWSR1, hnRNPA1, and hnRNPA2
Could Kapb2 antagonize RBP aggregation in vivo? First, we turned to yeast models where FUS, EWSR1, hnRNPA1, and hnRNPA2 mislocalize to the cytoplasm and aggregate as in neurodegenerative disease (Couthouis et al., 2011) . Kapb2, but not Kapb2 W460A:W730A , prevented formation of cytoplasmic FUS, EWSR1, hnRNPA1, and hnRNPA2 foci, and localized these RBPs to the nucleus ( Figures 5A and 5B). Kapb2 conferred this effect without reducing FUS, hnRNPA1, or hnRNPA2 expression, whereas EWSR1 expression was reduced (Figure S5A and 5B). Thus, in cells, Kapb2 chaperone activity depends on cargo possessing an intact PY-NLS.
To assess Kapb2 disaggregation activity in yeast, we expressed GFP-FUS from an inducible copper promoter for 2 hr to allow cytoplasmic FUS aggregates to accumulate ( Figure 5C ). Indeed, at this time, all cells had cytoplasmic FUS foci and FUS was not in the nucleus (Figures 5C and 5D) . FUS expression was then turned off and Kapb2 or Kapb2 W460A:W730A was expressed for 3 hr ( Figure 5C ). Immunoblots confirmed that FUS levels declined and Kapb2 or Kapb2 W460A:W730A was expressed as expected ( Figure S5B ). Kapb2, but not Kapb2 W460A:W730A , eliminated preformed GFP-FUS foci and localized GFP-FUS to the nucleus ( Figures 5C and 5D ). Similar results were obtained if FUS expression was not turned off ( Figure 5D ). Thus, Kapb2 reverses cytoplasmic FUS aggregation and restores FUS to the nucleus.
Kapb2 Reduces FUS Accumulation in SGs
Many RBPs with PrLDs become concentrated in SGs, which are cytoplasmic RNP granules that form upon stress. Elevated local concentrations of RBPs with PrLDs in SGs accentuates the risk of aberrant phase transitions and pathological fibrillization. Thus, restricting accumulation of RBPs with PrLDs in SGs could be neuroprotective (March et al., 2016) . In stressed human cells, Kapb2 is recruited to SGs ( Figure S5C ). Elevating Kapb2 expression did not inhibit SG formation as the SG assembly factor, G3BP1, still formed SGs (Figures 5E and S5D in SGs ( Figure S5G ). We then expressed Kapb2 or Kapb2 TL for 24 hr, after which only $5.3% of cells had FUS R521C in SGs, whereas GFP or Kapb2 W460A:W730A had no effect (Figure S5G Figure S4 and Movies S1, S2, S3, and S4. 
Kapb2 Buffers FUS Toxicity Expression of FUS or ALS-linked FUS R521H in human HEK293T
cells causes toxicity (Sun et al., 2011 Figure S6D ). In FUS R521H ALS-patient fibroblasts, expression of three FUS mRNA targets, TPST2, WNT5A, and ITGA3, was decreased $2-fold compared to controls ( Figure S6E ). In FUS R521H ALS-patient fibroblasts, Kapb2 restored TPST2, WNT5A, and ITGA3 expression back to control levels (Figure S6E) . Thus, increasing Kapb2 expression could combat FUS loss of function in ALS/FTD.
Reducing Kapb2 Enhances FUS-Linked Neurodegeneration in Drosophila Does reducing Kapb2 levels enhance FUS-linked neurodegeneration in vivo?
To answer this question, we used Drosophila where expression of ALS-linked FUS variants recapitulates several ALS phenotypes, including locomotion defects, neurodegeneration, cytoplasmic FUS mislocalization and aggregation, and reduced lifespan (Daigle et al., 2013) . We expressed FUS, FUS R521H , FUS P525L , or FUS R518K in the fly eye, which causes a rough eye phenotype and neurodegeneration ( Figure S7A ). FUS induces a slight rough eye phenotype, whereas FUS R521H , FUS P525L , and FUS R518K are more severe (Figures S7A and S7B) . We reduced Kapb2 expression by $60%-80% using RNAi in two independent lines (Figure S7C) (Figure 5I ). Co-expression of Kapb2 in adult motor neurons increased lifespan to $18.6 days, whereas co-expression of GFP had no effect (Figure 5I -mediated degeneration in a MSP-relevant tissue, i.e., muscle, in an intact animal. MSP-hnRNPA2 D290V most commonly presents with inclusion body myopathy . Hence, we tested whether Kapb2 mitigates muscle degeneration caused by MSP-linked hnRNPA2 D290V in fly. When expressed in fly indirect flight muscles, hnRNPA2 caused mild disruption of muscle fiber organization and partial wasting revealed by staining F-actin with Texas Red-phalloidin ( Figure 7A , white arrows). hnRNPA2 was mostly nuclear and detergent soluble ( Figures 7B and 7C ). By contrast, MSP-linked hnRNPA2 D290V caused severe muscle degeneration with disorganization and loss of muscle fibers ( Figure 7A , white arrows). hnRNPA2 D290V exhibited extensive cytoplasmic mislocalization and aggregation ( Figure 7B , white arrows), nuclear exclusion ( Figure 7B , yellow arrowheads), and detergent insolubility (Figure 7C ). Kapb2 reduced disruption of muscle fibers and partial wasting caused by hnRNPA2 and prevented hnRNPA2 D290V -driven muscle degeneration ( Figure 7A ). Indeed, flies now had normal muscles comparable to non-transgenic controls ( Figure 7A ). Kapb2 reduced the amount of hnRNPA2 and hnRNPA2 D290V in detergent-insoluble (i.e., urea soluble) fractions by $6-fold and $2.2-fold, respectively ( Figure 7C ). Kapb2 mildly reduced hnRNPA2 and hnRNPA2 D290V expression ( Figure 7D ). This effect of Kapb2 on hnRNPA2 and hnRNPA2 D290V expression is specific as RNAi of fly Kapb2 increased hnRNPA2 and hnRNPA2 D290V ( Figure S7D ). This increase in hnRNPA2 D290V is accompanied by a $1.4-fold increase of hnRNPA2 D290V in the detergent-insoluble fraction ( Figure S7E ). Thus, Kapb2 inhibits hnRNPA D290V aggregation. Indeed, Kapb2 reduced cytoplasmic hnRNPA2 Figure 7E ). Thus, NIRs do not merely function in nuclear import and are not merely chaperones (Jä kel et al., 2002; Milles et al., 2013) . Rather, they perform additional functions in reversing aberrant phase transitions and disaggregating their cargo in the cytoplasm. We establish that NIRs also selectively extract their cargos from condensed liquid phases thereby regulating functional phase separation. Collectively, these activities enable NIRs to shape the contents and architecture of cytoplasmic membraneless organelles. Thus, NIRs profoundly (legend continued on next page)
influence cellular organization beyond their canonical role in nuclear import. Impa and Kapb1 engage the cNLS to prevent and reverse TDP-43 fibrillization, whereas Kapb2 engages PY-NLSs to prevent and reverse FUS, TAF15, EWSR1, hnRNPA1, and hnRNPA2 fibrillization. Kapb2 prevents and reverses FUS LLPS (Hofweber et al., 2018; Yoshizawa et al., 2018;  in this issue of Cell). Kapb2 also reverses aberrant phase transitions of FUS and hnRNPA1 that result in fibrillar hydrogels, which are linked to neurodegeneration (Molliex et al., 2015; Murakami et al., 2015; Patel et al., 2015 Kapb2 with reduced affinity (Zhang and Chook, 2012) , could be chaperoned and disaggregated by high concentrations of Kapb2. Nonetheless, deletion of the NLS from RBPs reduced NIR chaperone or disaggregation activity. Thus, the NLS is not simply a signal that promotes nuclear import. Rather, the NLS is an anti-aggregation and disaggregation signal, which ensures nuclear cargo is chaperoned and disaggregated in the cytoplasm. Notably, $75% of human PrLD-containing proteins harbor a cNLS or PY-NLS. Thus, NIRs likely function broadly to antagonize aberrant phase transitions of proteins with PrLDs. A major therapeutic goal in ALS/FTD is to restore nuclear function of RBPs such as FUS that are mislocalized to cytoplasmic aggregates in degenerating neurons. FUS fibril dissolution by Kapb2 yields soluble Kapb2:FUS complexes, which are competent for nuclear transport. Upon arrival in the nucleus, Ran GTP completes the disaggregation reaction by releasing FUS from Kapb2. FUS can then perform its nuclear function and Kapb2 can be recycled to catalyze further rounds of chaperone, disaggregation, and transport activity. Thus, NIRs provide a therapeutic strategy to dissolve cytoplasmic RBP aggregates and restore nuclear RBP localization and function. Indeed, Kapb2 mitigated FUS loss of function in ALS-patient fibroblasts.
Kapb2 must initially engage the PY-NLS to disaggregate RBP fibrils. This binding may enable Kapb2 to extract individual RBPs from fibrils via entropic pulling. However, unlike Kapb2, an antibody that binds the FUS PY-NLS is unable to dissolve FUS fibrils, arguing against simple versions of this model. The PrLD engages in cross-b contacts that maintain RBP fibrils (Murray et al., 2017) . If the PY-NLS is not in the PrLD, then Kapb2 rapidly disaggregates fibrils as with FUS, TAF15, and EWSR1. Kapb2 binding to the PY-NLS may elicit a long-range allosteric conformational change in the PrLD that breaks cross-b fibril contacts. Alternatively, initial PY-NLS binding may enable Kapb2 to engage secondary binding sites in the FUS PrLD and rapidly disrupt contacts that maintain fibril integrity (Yoshizawa et al., 2018) .
If the PY-NLS is located in the PrLD, then Kapb2 slowly disaggregates fibrils as with hnRNPA1 and hnRNPA2. Here, Kapb2 binding to the PY-NLS breaks contacts that hold the fibril together. However, accessing the PY-NLS in hnRNPA1 or hnRNPA2 fibrils is likely more difficult because it is sequestered from solvent in the cross-b fibril core (Xiang et al., 2015) . Nonetheless, thermal fluctuations may enable Kapb2 to access the PY-NLS to slowly drive disaggregation of hnRNPA1 and hnRNPA2 fibrils.
Fibril-dissolution activity enables Kapb2 to dissolve macroscopic hydrogels formed by RBP fibrils. Kapb2 breaks multiple, weak hydrophobic contacts in hydrogels formed by FG-repeat rich nucleoporins to cross the nuclear pore during nuclear transport (Schmidt and Gö rlich, 2016) . NIRs carry multiple bindingpockets for FG-repeat-rich nucleoporins (Schmidt and Gö rlich, 2016) . This multivalency equips NIRs to break multiple transient intermolecular contacts between FG-repeat-rich nucleoporins, thus enabling specific and rapid passage across the nuclear pore. We suggest this multivalency also enables NIRs to rapidly break intermolecular contacts that maintain RBP liquids or RBP fibrils in gel phases (Monahan et al., 2017; Murray et al., 2017; Yoshizawa et al., 2018) . This Kapb2 activity weakens hydrogels formed by PrLD-containing RBPs without a functional PY-NLS, but when coupled to tight PY-NLS binding induces gel dissolution.
Kapb2 inhibits seeded fibrillization of RBPs, which could prevent pathological spreading by prion-like conformers. Kapb2 also dissolves RBP fibrils and reverses aberrant phase transitions of RBPs, which could be neuroprotective. Indeed, elevating Kapb2 expression antagonized motor-neuron degeneration and extended lifespan in flies expressing ALS-linked FUS R521H . Likewise, Kapb2 antagonized muscle degeneration caused by MSP-linked hnRNPA2 D290V in fly. Increased NIR expression also buffers toxicity caused by C9orf72 dipeptide-repeat proteins (Kim and Taylor, 2017) . In neurodegenerative diseases, NIRs may become overwhelmed and fail to counter excessive TDP-43, FUS or hnRNPA1 aggregation. Indeed, NIR expression is reduced in ALS/FTD patient brains (Kim and Taylor, 2017; Nishimura et al., 2010) . Arginine methylation adjacent to the PY-NLS weakens interactions between Kapb2 and FUS, and may reduce Kapb2 activity in FTD (Hofweber et al., 2018) . Moreover, Kapb2 is sequestered in cytoplasmic inclusions in FTD, which may limit activity (Kim and Taylor, 2017 (E) In ALS/FTD, nuclear RBPs with PrLDs mislocalize to the cytoplasm and upon stress localize to SGs where they undergo aberrant phase transitions to pathological fibrils. Upregulating Kapb2 reverses aberrant phase transitions and solubilizes aggregated RBPs. Once solubilized, Kapb2 transports RBPs back to the nucleus where Ran GTP dissociates Kapb2:RBP complexes enabling RBPs to perform nuclear functions and Kapb2 to be recycled to catalyze further rounds of disaggregation. See also Figure S7 .
signal-dependent disaggregation activity extends to other transport factors that recognize short linear motifs such as signalrecognition particles (Jaru-Ampornpan et al., 2010), peroxisomal-import factors, tail-anchored-protein targeting factors, and nuclear-export factors. These agents may reverse aberrant phase transitions in diverse settings.
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EXPERIMENTAL MODEL AND SUBJECT DETAIL
Yeast Strains and Media BY4741 yeast cells (MATa his3 leu2 met15 ura3) were grown in rich media (YPD) or in synthetic media lacking L-histidine and uracil and containing 2% glucose (SD/-His-Ura), raffinose (SRaf/-His-Ura), or galactose (SGal/-His-Ura).
Cell Culture
Human HEK293T cells (female) and HeLa cells (female) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% L-glutamate. Primary and immortalized fibroblasts from 3 healthy individuals (one 49-year-old female, one 50-year old male, and one 60-year old male) and 3 ALS patients (one 36-year old female, one 41-year old female, and one 70-year old male) harboring a FUS R521H mutation were grown in high-glucose DMEM/F12 (Thermofisher Scientific) supplemented with 20% (vol/vol) tetracycline-free FBS (Sigma), 1% (vol/vol) penicillin/streptomycin (Thermofisher Scientific). Fibroblasts were derived from skin biopsies after patients provided written informed consent at the VIB-KU Leuven and all experimental procedures were approved by the Institutional Review Board at the Massachusetts General Hospital.
Isogenic ReNcell VM human neural progenitors (male) were maintained in high-glucose DMEM/F12 (ThermoFisher Scientific) media supplemented with 2 mg.mL -1 heparin (StemCell Technologies, #07980), 2% (v/v) B27 neural supplement (ThermoFisher Scientific, #175004044), 20 mg.mL -1 hEGF (Sigma-Aldrich, #E9644), 20 mg.mL -1 bFGF (Stemgent, #03-0002) and 1% penicillin/ streptomycin (ThermoFisher Scientific) and were plated onto Matrigel (BD Biosciences)-coated cell culture 24-well format coverslips. Drosophila maintenance, strains, and genetics Fly lines were maintained on standard food using standard methods as described previously (Lanson et al., 2011) . UAS-Kab2 RNAi strains (stock # v6543 and v6544) were obtained from the Vienna Drosophila Resource Centre (VDRC). UAS-HA-FUS strains have been previously described (Lanson et al., 2011) . UAS-Kapb2 strains were made using random integration of plasmids pUAST-Kab2. Microinjection of these plasmids was performed by BestGene. Flies expressing wild-type hnRNPA2 and D290V mutant form of hnRNPA2 have been described previously . The GFP-tagged wild-type Karyopherin-b2 cDNAs were subcloned into the pUASTattB plasmid, using restriction sites NotI and XbaI, creating pUASTattB-wild-type GFP-Karyopherin-b2. Flies carrying pUASTattB transgenes were generated by a standard injection and QC31 integrase-mediated transgenesis technique. To express a transgene in muscles, Mhc-Gal4 was used . All Drosophila stocks were maintained in a 25 C incubator with a 12h day/night cycle.
METHODS DETAILS
Protein purification All proteins were expressed and purified from E. coli BL21-CodonPlus(DE3)-RIL cells (Agilent) and purified under native conditions unless otherwise noted. RBP expression constructs were generated in pGST-Duet to contain a TEV-cleavable site, resulting in a GST-TEV-RBP construct. GST-TEV-FUS, GST-TEV-His-FUS, GST-TEV-FUS
, GST-TEV-FUS R521H , and GST-TEV-FUS D498-526 (FUS DNLS ) were purified as described (Sun et al., 2011) . E.coli cells were lysed by sonication on ice in PBS with protease inhibitors (cOmplete, EDTA-free, Roche Applied Science). The protein was purified over Glutathione Sepharose 4 Fast Flow (GE Healthcare) and eluted from the beads using 50mM Tris-HCl, pH 8, 20 mM trehalose, and 20mM glutathione. GST-TEV-TDP-43, GST-TEV-TDP-43 Q331K , GST-TEV-TDP-43 , and GST-TEV-TDP-43 D79-98 were purified as described (Johnson et al., 2009 ), GST-TEV-hnRNPA1,
(hnRNPA1 DNLS ), GST-TEV-hnRNPA2, GST-TEV-hnRNPA2 D290V , and GST-TEV-hnRNPA2 D293-319 (hnRNPA2 DNLS ) were purified as described . For GST-TEV-TDP-43, GST-TEV-hnRNPA1, and GST-TEV-hnRNPA2, E.coli cells were lysed by sonication on ice in 40mM HEPES-KOH (pH 7.4), 5mM EDTA, 300mM KCl, 1mM DTT, 5% glycerol, 5 mM pepstatin, 10mg/Liter RNase A and protease inhibitors (cOmplete, EDTA-free, Roche Applied Science). The protein was purified over Glutathione Sepharose 4 Fast Flow (GE Healthcare) and eluted from the beads using 40mM HEPES-KOH (pH 7.4), 150mM NaCl, 5% glycerol, and 20mM reduced glutathione. GST-TEV-TAF15, GST-TEV-TAF15
G391E
, GST-TEV-TAF15 R408C , GST-TEV-TAF15 D572-592 (TAF15 DNLS ) were purified as described (Couthouis et al., 2011) . GST-TEV-EWSR1, GST-TEV-EWSR1
G511A , GST-TEV-EWSR1 P552L , and GST-TEV-EWSR1 D630-655 (EWSR1 DNLS ) were purified as described (Couthouis et al., 2012) . These proteins were overexpressed in E. coli BL21 Star (Invitrogen) and eluted from the glutathione sepharose with 50mM Tris-HCl, pH 7.4, 100mM potassium acetate, 200mM trehalose, 0.5mM ethylenediaminetetraacetic acid (EDTA) and 20mM glutathione. Hsp104 and Hsp104 A503S were purified as untagged proteins as described (Jackrel et al., 2014) . Cells were harvested, lysed with lysis buffer (50mM Tris-HCl, pH 8.0, 10mM MgCl 2 , 2.5% glycerol, 2mM b-mercaptoethanol) supplemented with protease inhibitors, and the protein was purified using Affi-Gel Blue Gel (Bio-Rad). The protein was eluted with elution buffer (50mM Tris-HCl, pH 8.0, 1M KCl, 10mM MgCl 2 , 2.5% glycerol, 2mM b-mercaptoethanol) and further purified by ResourceQ anion exchange chromatography using running buffer Q (20mM Tris-HCl, pH 8.0, 0.5mM EDTA, 5mM MgCl 2 , 50mM NaCl) and eluted with a linear gradient of buffer Q+ (20mM Tris-HCl, pH 8.0, 0.5mM EDTA, 5mM MgCl 2 , 1M NaCl). Immediately before loading the column, the protein was diluted to a final concentration of 10% in buffer Q supplemented to 150mM NaCl and loaded onto the column.
Apg2, Sse1, Ssa1, and Ydj1 were purified as described (Shorter, 2011) . Briefly, Apg2 was purified via sequential DEAE-Sepharose and DMAE-Sepharose anion exchange chromatography. Both anion-exchange steps were performed in 25mM HEPES-KOH, pH 7.6, 50mM KCl, 1mM EDTA, 10mM b-mercaptoethanol, and 10% glycerol. Apg2 was eluted with a linear 55-500 mM KCl gradient. To remove further impurities, purified fractions were pooled, concentrated by ammonium sulfate precipitation and fractionated via Sephacryl 300 gel filtration in 25mM HEPES-KOH, pH 7.6, 50mM KCl, 5mM MgCl 2 , plus 5% glycerol. Sse1 was purified with a similar protocol except that the gel filtration step was replaced by a hydroxyapatite column, equilibrated in 10mM K x H y PO 4 , pH 7.6, 5mM MgCl 2 , and 5% glycerol. Sse1 was eluted with a linear 10-500 mM phosphate gradient.
Ssa1 were expressed as an N-terminally His-tagged protein. Cells were lysed by sonication in 40mM HEPES-KOH. pH 7.4, 500mM KCl, 20mM MgCl 2 , 5% (w/v) glycerol, 20mM imidazole, 5mM ATP, 2mM b-mercaptoethanol, 5mM pepstatin A, and Complete protease inhibitor cocktail. Cell debris was removed by centrifugation (40,000 g, 20min, 4 C), and the supernatant applied to Ni-NTA agarose. The column was then washed with 25 volumes of WB (40mM HEPES-KOH, pH 7.4, 150mM KCl, 20mM MgCl 2 , 5% (w/v) glycerol, 20mM imidazole, 5mM ATP, and 2mM b-mercaptoethanol), 5 volumes of WB plus 1M KCl, and 25 volumes of WB. Protein was eluted with WB plus 350mM imidazole, and purified further by sucrose gradient (5%-30% w/v in WB) velocity sedimentation. Peak fractions were collected and exchanged into 40mM HEPES-KOH, pH 7.4, 150mM KCl, 20mM MgCl 2 , 10% (w/v) glycerol, 5mM ATP and 1mM DTT. The His-tag was then removed with His-TEV (Invitrogen), and any uncleaved protein and His-TEV were depleted with Ni-NTA.
Ydj1 was overexpressed in BL21 (DE3) E. coli cells, which were lysed in buffer containing 20mM MOPS, pH 7.5, 0.5mM EDTA, 10mM DTT, and 0.5 mM PMSF (phenylmethylsulfonyl fluoride). Cleared lysate was loaded onto a DE52 column (Whatman) equilibrated with buffer containing 20mM MOPS, pH 7.5, 0.5mM EDTA, 10mM DTT, and 0.5 mM PMSF. Ydj1 was eluted with a 0-300 mM NaCl gradient. Peak fractions containing Ydj1 were pooled, dialyzed against buffer containing 5mM potassium phosphate, pH 7.0, and 10mM DTT and then purified over a hydroxyapatite column. The protein was then eluted with a linear 5-400 mM potassium phosphate gradient and dialyzed against buffer containing 10mM HEPES-KOH, pH 7.4, 50mM NaCl, 10mM DTT, and 10% glycerol.
Kapb2 and Kapb2 W460A:W730A were purified as described (Lee et al., 2006) . Impa and Kapb1 were purified as described (Zhang et al., 2011) . GST-Importins were expressed individually in BL21 (DE3) E. coli cells, which were lysed in buffer containing 50mM pH 7.5, 200mM NaCl, 20% (v/v) glycerol, 2mM DTT, 1mM EDTA, and protease inhibitors. GST-Importins were then purified by affinity chromatography using GSH Sepharose beads (GE Healthcare, UK), eluted, cleaved with TEV protease, and further purified by ion-exchange and gel filtration chromatography in buffer (20mM HEPES-NaOH, pH 7.4, 200mM NaCl, 2mM DTT, 2mM magnesium acetate, 10% glycerol, and 1mM EGTA). Ran Q69L was purified and loaded with GTP or GDP as described (Zhang et al., 2011) . The protein was expressed in E. coli BL21-DE3 and purified from a French press lysate in buffer (20 mM HEPES, pH 7.3, 110 mM potassium acetate, 5 mM magnesium acetate, 1 mM EGTA, 10 mM DTT, 20% glycerol) containing 10 mM GDP, via sequential Q-Hi-Trap, SP Hi-Trap and Superdex-75 chromatography (Pharmacia). Hsc70 and Hdj1 were from Enzo Life Sciences. Anti-FUS rabbit polyclonal antibody (NB100-562) was from Novus. HDAC1 was from BPS Bioscience. TEV protease was from Invitrogen. Firefly luciferase was from Sigma.
Spontaneous fibril assembly- Figure 1 , Figure S1 Spontaneous FUS (and disease-linked variant) fibrillization (i.e., in the absence of preformed fibril seeds) was initiated by addition of TEV protease to GST-TEV-FUS (5mM) in FUS assembly buffer (50mM Tris-HCl, pH 8, 200mM trehalose, 1mM DTT, and 20mM glutathione) (Couthouis et al., 2011 (Couthouis et al., , 2012 Sun et al., 2011) . Spontaneous FUS fibrillization reactions were incubated at 25 C for 90min without agitation at which time fibrillization was complete with $100% of FUS in the aggregated state. Spontaneous EWSR1, TAF15, and TDP-43 (and disease-linked variants) fibrillization was initiated by addition of TEV protease to GST-TEV-RBP (5mM) in ETT assembly buffer (50mM Tris-HCl, pH 7.4, 200mM trehalose, 100mM potassium acetate, 0.5mM EDTA, and 20mM glutathione). Spontaneous EWSR1, TAF15, TDP-43 fibrillization reactions were incubated at 25 C for 90 min with agitation at 700rpm in an Eppendorf Thermomixer at which time fibrillization was complete with $100% of the RBP in the aggregated state. TDP-43 DNLS took longer to fibrillize, and thus was incubated at 25 C for 16h with agitation at 700rpm at which time fibrillization was complete with $100% of the TDP-43 DNLS in the aggregated state. For hnRNPA1 and hnRNPA2 fibrillization (and disease-linked variants), GST-TEV-hnRNPA1 or GST-TEV-hnRNPA2 (5 mM) were incubated with TEV protease in A1 assembly buffer (40mM HEPES-NaOH, pH 7.4, 150mM NaCl, 5% glycerol, 1mM DTT, and 20 mM glutathione). HnRNPA1 and hnRNPA2 fibrillization reactions were incubated at 25 C for 16h with agitation at 1,200rpm in an Eppendorf Thermomixer at which time fibrillization was complete with $100% of the hnRNP in the aggregated state. No RBP fibrillization occurs in the absence of TEV protease (Couthouis et al., 2011 (Couthouis et al., , 2012 Kim et al., 2013; Sun et al., 2011) . Spontaneous fibrillization reactions were performed in the presence or absence of the indicated concentration of Kapb2 (5mM), Kapb2 W460A:W730A (5mM), or Impa (5mM) plus Kapb1 (5mM). To determine the half maximal inhibitory concentration (IC 50 ), Kapb2 was titrated into the above fibrillization reactions from 0.1-20mM. In some reactions, Ran Q69L -GDP or Ran Q69L -GTP (25mM) was also present, in which case GDP or GTP (1mM) were also present. In some FUS fibrillization reactions, HDAC1 (5mM or 50mM) or anti-FUS rabbit polyclonal antibody (NB100-562, Novus; 5mM) was also included.
Seeded fibril assembly-Figures 2 and S2
For 'seeded' assembly reactions, RBP fibrils were freshly prepared for each experiment. Fibril formation was confirmed by EM. These fibrils termed 'seed' were added at 5% (wt/wt) at the beginning of the fibrillization reaction. In this study, we only conducted selfseeding reactions, i.e., the primary sequence of the soluble RBP and fibrillar RBP were the same. FUS tends to form large tangles of fibrils, which must be dispersed prior to seeding reactions. Thus, FUS fibrils were formed for 3h as above, and then to separate fibrils an equal volume of high salt buffer (40mM HEPES-KOH, pH 7.4, 500mM KCl, 20mM MgCl 2 , 10% glycerol, and 1mM DTT) was added and the incubation was continued for 2h. Seeded assembly reactions were performed as above for spontaneous fibrillization except that seeded reactions were not agitated. For experiments in Figure 2H , FUS seeding reactions were incubated at 25 C for 20min, TAF15, EWSR1, hnRNPA2, and TDP-43 seeding reactions were incubated at 25 C for 2h, and hnRNPA1 seeding reactions were incubated at 25 C for 4h. At the end of these seeded fibrillization reactions, minimal fibrillization occurred in the absence of added seed, whereas $20%-50% of RBP was in the aggregated state in the presence of seed 5% (wt/wt). Seeded fibrillization reactions were performed in the presence or absence of the indicated concentration of Kapb2 (5mM), Kapb2
W460A:W730A (5mM), or Impa (5mM) plus Kapb1 (5mM).
Turbidity was used to assess spontaneous and seeded fibrillization by measuring absorbance at 395nm. The absorbance was then normalized to that of WT RBP plus buffer control to determine the relative extent of aggregation. Alternatively, sedimentation analysis was used to assess spontaneous and seeded fibrillization. Thus, reactions were centrifuged at 16,100 g for 10 min at 4 C. Supernatant and pellet fractions were then resolved by sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and stained with Coomassie Brilliant Blue or processed for immunoblot, and the amount in either fraction (% total) was determined by densitometry in comparison to known quantities of the RBP in question. For electron microscopy, fibrillization reactions (10 ml) were adsorbed onto glow-discharged 300-mesh Formvar/carbon coated copper grids (Electron Microscopy Sciences) and stained with 2% (w/v) aqueous uranyl acetate. Excess liquid was removed, and grids were allowed to air dry. Samples were viewed by a JEOL 1010 transmission electron microscope. Figures 3A-3F , S3A-S3C, and S3H). In other experiments, FUS fibrils (5mM monomer) were incubated at 25 C with Kapb2 (5mM), HDAC1 (5 or 50mM), or anti-FUS antibody (5mM) for 0-60min ( Figure 3H) . Alternatively, FUS, TAF15, or EWSR1 fibrils (5mM monomer) were incubated at 25 C with Hsp104 (5mM) plus Sse1 (a yeast Hsp110; 1mM), Ssa1 (a yeast Hsp70; 1mM), and Ydj1 (a yeast Hsp40; 1mM), Hsp104 A503S (5mM) plus Sse1 (1mM), Ssa1 (1mM), and Ydj1 (1mM), or human Hsp110 (Apg2; 5mM), human Hsp70 (Hsc70; 5mM), and human Hsp40 (Hdj1; 5mM) for 0-60min ( Figures S3D-S3F ). TDP-43 fibrils (5mM monomer) were incubated at 25 C with Kapb2 (5mM), Hsp104 A503S (5mM) plus Sse1 (an Hsp110; 1mM), Ssa1 (an Hsp70; 1mM), and Ydj1 (an Hsp40; 1mM), or Impa (5mM) plus Kapb1 (5mM) for 0-60min ( Figure 3J ). Figures 3L and 3M ). For reactions containing Hsp104 or Hsp110, MgCl 2 (20mM), ATP (5mM), and an ATP regeneration system comprised of creatine kinase (0.2mg/ml) and creatine phosphate (10mM) were also added. Fibril disaggregation was performed without agitation and was assessed by turbidity, sedimentation analysis, and EM as described above. To determine the half maximal inhibitory concentration (EC 50 ), Kapb2 was titrated into the above fibril disassembly reactions from 0-20mM ( Figure 3G ). For experiments in Figure 3I , Kapb2 was biotinylated with Sulfo-NHS-LC-Biotin (Thermofisher) to achieve $1-2 biotin moieties per Kapb2. Biotinylated Kapb2 (bio-Kapb2) retained maximal disaggregase activity. His-FUS fibrils (5mM monomer) were disassembled with bio-Kapb2 (5mM) for 2h. Neither the His-tag on FUS nor the biotin on Kapb2 affected the ability of Kapb2 to disaggregate FUS fibrils. The soluble disaggregation products were then recovered and incubated with Ran GDP or Ran GTP (25mM) for 30min. Soluble disaggregated products in the supernatant fraction were then depleted of bio-Kapb2 using Pierce NeutrAvidin UltraLink Resin (Thermofisher) or His-FUS using Ni-NTA agarose (QIAGEN) in the presence or absence of Ran GDP or Ran GTP (25mM).
Luciferase disaggregation and reactivation-Figure S3G
Luciferase disaggregation and reactivation was performed as described previously (Jackrel et al., 2014) . Chemically denatured firefly luciferase aggregates (50nM monomer) were incubated at 25 C for 90min with Kapb2 (5mM), Hsp104 (5mM) plus Sse1 (1mM), Ssa1 (1mM), and Ydj1 (1mM), Hsp104 A503S (5mM) plus Sse1 (1mM), Ssa1 (1mM), and Ydj1 (1mM), or Hsp110 (Apg2; 5mM), Hsp70 (Hsc70; 5mM), and Hsp40 (Hdj1; 5mM). Luciferase reactivation was then determined.
Liquid droplet formation and disassembly- Figure S4 FUS liquid droplets were formed by incubating GST-TEV-FUS (10mM) in the presence or absence of Kapb2 or Kapb2 W460A:W730A (10mM) in FUS assembly buffer (50mM Tris-HCl, pH 8, 200mM trehalose, 1mM DTT, and 20mM glutathione) for 4 hr at 25 C. Protein samples were then spotted onto a coverslip and imaged by Differential interference contrast (DIC) microscopy. In disassembly experiments, GST-TEV-FUS droplets or GST-TEV-FUS P525L (10mM monomer) were first formed via incubation for 4 hr at 25 C. Preformed droplets were then incubated with Kapb2 or Kapb2 W460A:W730A (10mM) for 3min at 25 C and monitored by DIC microscopy. Viscous hnRNPA1 liquids were formed by incubating GST-hnRNPA1 ($200mg/ml) in 40mM HEPES-NaOH, pH 7.4, 150mM NaCl, 5% glycerol, and 20mM glutathione on ice for 1h. Viscous GST-hnRNPA1 liquids were incubated with the indicated amount of Kapb2 or Kapb2
W460A:W730A at 4 C for 6 hr before being photographed.
Hydrogel formation- Figure 4 To generate hydrogels, GST-FUS 1-214 ($60mg/ml) in 20mM Tris-HCl, pH 7.5, 500mM NaCl, 20mM b-mercaptoethanol, 0.1mM PMSF, and 10mM glutathione was incubated on ice for at least one week. GST-FUS ($20-40mg/ml) in 50mM Tris-HCl, pH 8, 200mM trehalose, and 20mM glutathione was incubated on ice for at least one month to form hydrogels. GST-hnRNPA1 ($200mg/ml) in 40mM HEPES-NaOH, pH 7.4, 150mM NaCl, 5% glycerol, and 20mM glutathione was incubated on ice for at least one month to form hydrogels. GST-hnRNPA1 D262V ($33mg/ml) in 40mM HEPES-NaOH, pH 7.4, 150mM NaCl, 5% glycerol, and 20mM glutathione was incubated on ice for 24 hr to for hydrogels. For EM, the hydrogel samples were prepared following the same protocol as above but in the cold room. Hydrogels were also removed from tubes and stood on the benchtop for photography.
Hydrogel disassembly-Figure 4
All hydrogels were stored at 4 C until use. Buffer (20mM Imidazole, pH 6.5, 232mM NaCl, 1mM EDTA, 2mM DTT, and 20% glycerol), Kapb2, Kapb2 W460A:W730A , or GFP was added on top of the hydrogel (40ml (78mM, 200ml) to give a molar ratio of Kapb2:hnRNPA1 = 0.13. In other experiments, hnRNPA1 gels (1.99mM, 40ml) were treated for 24h at 25 C with buffer or GFP (215mM, 100ml) to give a molar ratio of GFP:hnRNPA1 = 0.27. hnRNPA1 D262V gels (0.51mM, 40ml) were treated for 24h at 25 C with buffer or Kapb2 (78mM, 200ml) to give a molar ratio of Kapb2: hnRNPA1 D262V = 0.76. Finally, hnRNPA1 G274A:P288A:Y289A gels (3mM, 40ml) were treated for 24h at 25 C with buffer or Kapb2 (78mM, 200ml) . Molar ratio of Kapb2: hnRNPA1 G274A:P288A:Y289A = 0.13. Samples were processed for photography, EM, or rheology (see below).
Rheology-Figures 4 and S4
For rheological measurements, the samples were separated into two phases by a short pulse spin, the top liquid phase was removed by pipetting and the bottom phase was used for rheology. For GST-FUS WT hydrogel, after adding Kapb2 for 24 hr, only one phase is observed. Therefore, after the short pulse spin, 40ml sample was taken from the bottom of the tube for rheology measurements. The viscoelastic properties of each hydrogel were characterized by rheological measurements on an AR2000 rheometer (TA Instruments) using a cone-plate geometry (20mm diameter, 59min 42 s cone angle, and 27mm gap) (Rodell et al., 2013) . To evaluate rheological properties, material responses to increasing strain were measured with oscillatory strain sweeps from 0.01 to 1000% strain at 1Hz. The frequency dependence of material properties to the application of strain were measured with oscillatory frequency sweeps from 0.01 to 100Hz at 0.5% strain. Reported storage modulus (G') and loss modulus (G'') values were averaged value from 5-minute time sweeps at 4 C, 1Hz and 0.5% strain, corresponding to the plateau range of the hydrogels examined.
Yeast Procedures
Yeast procedures were performed according to standard protocols (Sun et al., 2011) . We used the PEG/lithium acetate method to transform yeast with plasmid DNA. Yeast cells were grown in rich media (YPD) or in synthetic media lacking L-histidine and uracil and containing 2% glucose (SD/-His-Ura), raffinose (SRaf/-His-Ura), or galactose (SGal/-His-Ura). A Kapb2 Gateway entry clone was generously provided by Gideon Dreyfuss containing full-length human Kapb2 in pDONR221. A Gateway LR reaction was used to shuttle Kapb2 into the Gateway-compatible yeast expression vector pAG413Gal-ccdB. A galactose-inducible GFP-FUS (pYES2CT/GFP-FUS) construct was generously provided by Gregory Petsko (Ju et al., 2011) . A copper-inducible GFP-FUS (p426CUP-GFP-FUS) was also generated. QuikChange Site-Directed Mutagenesis Kit (Agilent) was used to generate mutant plasmids according to the manufacturer's instructions. Mutations were verified by DNA sequencing. The pAG413Gal-Kapb2 and pYES2CT/GFP-FUS constructs were transformed into BY4741 (MATa his3 leu2 met15 ura3).
Yeast Western Blotting-Figures S5A and S5B
Yeast lysates were extracted after incubation with 0.2M NaOH at room temperature for 5 min. Lysates were then subjected to Tris-HCl SDS-PAGE (4%-20% gradient, Bio-Rad) and transferred to a PVDF membrane (Millipore). Membranes were blocked in Odyssey Blocking Buffer (LI-COR) overnight at 4 C. Primary antibody incubations were performed at room temperature for 1-2 h. After washing with PBS+0.05% Tween 20 (PBST), membranes were incubated with fluorescently labeled secondary antibodies at room temperature for 1 h, followed by washing with PBST. Proteins were detected using an Odyssey Fc Dual-Mode Imaging system. Primary antibody dilutions were as follows: anti-Kapb2 monoclonal antibody (Sigma-Aldrich), 1:5000; anti-FUS rabbit polyclonal antibody (Bethyl), 1:5000. Fluorescently labeled anti-mouse and anti-rabbit secondary antibodies were used at 1:5000.
Yeast Fluorescence Microscopy-Figures 5A-5D
For fluorescence microscopy experiments, yeast were grown to mid-log phase in SRaf/-His-Ura media at 30 C. Cultures were diluted to an OD600 of 0.4 in SGal/-His-Ura to induce expression of Kapb2 or Kapb2 W460A:W730A and the indicated FUS, EWSR1, hnRNPA1, or hnRNPA2 variant. Cultures were induced with galactose for 4-6h before being stained with Hoechst dye to visualize nuclei and processed for microscopy (Sun et al., 2011) . In some experiments, yeast were grown overnight at 30 C in SRaf/-His-Ura and then diluted to OD600 of 0.8 in SRaf/-His-Ura plus 20mM CuSO 4 to induce GFP-FUS for 2h at 30 C. Cells were then transferred to SGal/-His-Ura to induce Kapb2 for 3h at 30 C. Cultures were then stained with Hoechst dye to visualize nuclei and processed for microscopy. Images were obtained using an Olympus IX70 inverted microscope and a Photometric CoolSnap HQ 12-bit CCD camera. Z stacks of several fields were collected for each strain. Representative cells were chosen for figures. At least 100 cells per sample were counted for each replicate.
HEK293T and HeLa Cell culture and transfection- Figures 5E-5H , S5, and S6 HEK293T and HeLa cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, and 1% L-glutamate. Cells were transfected using either Lipofectamine LTX with Plus Reagent (Invitrogen) or FuGENE 6 Transfection Reagent, according to the manufacturer's instructions. downregulated in fibroblasts from FUS-R521H ALS patients (TPST2, WNT5A, ITGA3) were determined by quantitative RT-PCR after 72h of Kapb2 induction. Quantitative RT-PCR was carried out using the iTaq universal sybr green supermix kit (BioRad), one denaturation step at 95 C for 5 min, 45 cycles of amplification (95 C for 10 s, 58 C for 30 s), then 65 C for 5 s and a final step at 95 C for 50 s using the specific human primers for RPLP0 (Forward: GAAGTCACTGTGCCAGCCCA, Reverse: GAAGGTGTAATCCGTCTCCA), for Kapb2 (TNPO1) (Forward: TCCCTTTACTTGAGTGCCTATC; Reverse: TAGCATGGCTTGTGCAAGAG), for TPST2 (Forward: CAAC AAGGACCCATTTACGCTC, Reverse: TACACAGGCAGGCACTTCTCC), for WNT5A (Forward: CATGAACCTGCACAACAAC, Reverse: AGCATGTCTTCAGGCTACAT) and for ITGA3 (Forward: TGGCAGACCTACCACAACG, Reverse: CTGGCTCAGCAAGA ACACC).
Quantitative PCR in fly- Figure S7 7 fly heads from age-matched flies were collected per sample and RNA was purified from the fly heads using Trizol reagent. cDNA was derived from RNA by reverse transcription. Expression of the endogenous Drosophila Kapb2 gene was measured using qPCR and normalized against the expression level of alpha-Tubulin-84b.
Kapb2 primer sequence: 5 0 /56-FAM/CATTATCAA/ZEN/CCGCCCGAACACGC/3IABkFQ/3 0 ; 5 0 GGAGACCAAGCAGTACATACG3 0 ; 5 0 GCAAATAAGGAGCCACTTCAAC3 0 . Alpha-Tubulin-84b primer sequence: 5 0 /56 FAM/TCACACGCG/Zen/ACAAGGAAAATTCACAGA/3IABkFQ/3 0 ; 5 0 CCTCGAAATCG TAGCTCTACAC3 0 ; 5 0 ACCAGCCTGACCAACATG3 0 . The qPCR data were analyzed using the statistics software package Graphpad Prism.
Drosophila eye images and quantification-Figure S7
The left eyes of 2-day old female flies were photographed using a Leica M205C stereomicroscope. Fly eye phenotypes were assessed using a quantitative scale in which points were assigned for the following criteria: disorder in the ommatidial array; ommatidial fusion; altered appearance of hairs between the ommatidia; loss of pigmentation; speckling or presence of individual ommatidia with obviously different pigmentation; increased reflectiveness of the eye surface; presence of necrotic patches; decreased size of the eye. For each criterion, points were assigned based on the extent of the abnormality. 10 flies were assessed for each genotype. For each separate experiment the control and experimental flies were assessed at the same time.
Drosophila lifespan experiments- Figure 5 OK371-HA-FUS R521H males were crossed with virgin females at 18 C, which ensures low expression of HA-FUS R521H and eclosion of adult flies. The OK371-HA-FUS-R521H strain must be maintained at 18 C or lower to be viable. F1 progeny females were collected on the day of eclosion and placed at 28 C for lifespan measurements.
Adult fly muscle preparation and immunohistochemistry- Figure 7 For immunostaining of indirect flight muscles, female flies were used because they have a bigger thorax. Adult flies were embedded in a drop of OCT compound (Sakura Finetek) on a glass slide, frozen with liquid nitrogen and bisected sagitally by a razor blade. After fixing with 4% paraformaldehyde in PBS, hemithoraces were stained by Texas Red-X phalloidin (Invitrogen) and DAPI according to manufacturer's instructions. Stained hemi-thoraces were mounted in 80% glycerol, and the musculature was examined by DMIRE2 (Leica, 103). For hnRNPA2 staining, hemithoraces were permeabilized with PBS containing 0.2% Triton X-100 and stained with antihnRNPA2B1 antibody (Santa Cruz Biotechnology) and Alexa 488-conjugated secondary antibody (Invitrogen). Stained muscle fibers were dissected and mounted in Fluormount-G (Southern Biotech) and imaged with a Marianas confocal microscope (Zeiss, 363).
Fly western blotting-Figures 7 and S7
For western blot, male and female flies were used with 1:1 ratio. Thoraces of adult flies were prepared and ground in PBS containing 0.2% Triton X-100. After adding SDS sample buffer, samples were boiled for 5 min and analyzed by the standard western blotting method provided by Odyssey system (LI-COR) with 4%-12% NuPAGE Bis-Tris Gel (Invitrogen) and anti-hnRNPA2B1 antibody (Santa Cruz, 1:1,000).
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical parameters including the definitions and exact values of n (e.g., number of biological repeats, number of flies, number of cells, etc), distributions and deviations are reported in the Figures and corresponding Figure Legends (or STAR Methods section). p > 0.05, not significant, *p < 0.05, **p < 0.01 and ***p < 0.001 by Student's t test, one-way ANOVA, two-way ANOVA or Log-rank test. Dunnett or Bonferroni correction were used in ANOVA to control family-wise error rate of the tested simple effects, separately per level of the second factor (e.g., time point) in two-way ANOVA. Statistical analysis was performed in GraphPad Prism or Excel. 
